590
VARIZHUK et al.
(2 H, q, J 7.14, Ha OCH2CH3), 4.00–3.92 (2 H, m, H3', CH3COO), 2.102 (1 H, m, H5'a), 2.007 (1 H, m, H5'b),
H4'), 2.409 (2 H, m, H6'a, H6'b), 2.095 (3 H, s,
2'-CH3COO), 2.059 (1 H, m, H5'a), 1.926 (3 H, s, br,
J 1.14, 5-CH3), 1.914 (1 H, m, H5'b), 1.277 (3 H, t,
J 7.14, OCH2CH3).
1.199 (3 H, t, J 7.13, OCH2CH3).
2'-O-Acetyl-3'-é-benzoyl-5'-deoxy-5'-ethoxycar-
bonylmethyl-2-N-acetylguanosine
(IXe)
was
obtained from 2-N-acetylguanine (0.184 g, 0.95 mmol)
in absolute acetonitrile (5 ml), BSA (0.67 g, 0.81 ml,
3.3 mmol), diacetate (VIII) (0.34 g, 0.86 mmol) (a solu-
tion in 4 ml of absolute acetonitrile), and trimethylsilyl-
triflate (0.22 g, 0.18 ml, 1 mmol). Elution with metha-
nol–chloroform 1 : 49 yielded 0.33 g (72.6%) of nucle-
2'-O-Acetyl-3'-é-benzyl-5'-deoxy-5'-ethoxycar-
bonylmethylcytidine (IXb) was obtained from
cytosine (0.16 g, 1.42 mmol) in absolute acetonitrile
(6 ml), BSA (1 g, 1.2 ml, 4.9 mmol), diacetate (VIII)
(0.43 g, 1.1 mmol) (a solution in 4 ml of absolute ace-
tonitrile), and trimethylsilyltriflate (0.32 g, 0.26 ml,
1.42 mmol). Elution with methanol–chloroform 1 : 24
yielded 0.44 g (90.6%) of nucleoside (IXb) as a solid
foam; Rf 0.39 (F). 1H NMR (CDCl3): 7.39–7.26 (5 H, m,
Ph), 7.348 (1 H, d, J5,6 7.42, H6), 5.798(1 H, d, J5,6 7.42,
H5), 5.719 (1 H, d J1',2' 2.06, H1'), 5.494 (1 H, dd, J1',2'
1
oside (IXe) as a solid foam; Rf 0.56 (E). H NMR
(CDCl3): 7.662 (1 H, s, H8), 7.39–7.26 (5 H, m, Ph),
5.93 (1 H, d, J1',2' 5.76, H1'), 5.582 (1 H, pseudo s, t,
J 5.36, H2'), 4.542 (2 H, s, br, Ha, Hb PhCH2O), 4.359
(1 H, m, H3'), 4.229 (1 H, m, H4'), 4.126 (2 H, m,
OCH2CH3), 2.424 (2 H, m, H6'a, H6'b), 2.291 (3 H, s,
2-CH3CON), 2.058 (3 H, Ò, 2'-CH3COO), 2.09 (1 H, m,
H5'a), 2.005 (1 H, m, H5'b), 1.251 (3 H, t, J 7.11,
OCH2CH3).
2
2.06, J2',3' 5.29, H2'), 4.589 (1 H, d, Ja,b 11.23, Hb
PhCH2O), 4.411 (1 H, d, 2Ja,b 11.23, Hb PhCH2O), 4.106
(2 H, m, OCH2CH3), 3.995 (1 H, dt, J3',4' 8.17, J4',5'a 4.04,
J4',5'b 8.35, H4'), 3.876 (1 H, dd, J2',3' 5.29, J3',4' 8.17, H3'),
2.438 (2 H, m, H6'a, H6'b), 2.096 (3 H, s, 2'-CH3COO),
2.056 (1 H, m, H5'a), 1.923 (1 H, m, H5'b), 1.222 (3 H,
t, J 7.08, OCH2CH3).
ACKNOWLEDGMENTS
This work was supported by the Russian Foundation
for Basic Research (project no. 08-04-01078).
2'-O-Acetyl-3'-é-benzyl-5'-deoxy-5'-ethoxycar-
bonylmethyladenosine (IXc) was obtained from ade-
nine (0.16 g, 1.2 mmol) in absolute acetonitrile (5 ml),
BSA (0.84 g, 1 ml, 4.1 mmol), diacetate (VIII) (0.36 g,
0.91 mmol) (a solution in 4 ml of absolute acetonitrile),
and trimethylsilyltriflate (0.27 g, 0.22 ml, 1.2 mmol).
Elution with methanol–chloroform 1 : 49 yielded
0.23 g (53.7%) of nucleoside (IXc) as a solid foam;
Rf 0.55 (F). 1H NMR (CDCl3): 8.318 (1 H, s, H2), 8.054
(1 H, s, H8), 7.39–7.26 (5 H, m, Ph), 5.997 (1 H, d, J1',2'
3.05, H1'), 5.854 (1 H, dd, J1',2' 3.05, J2',3' 5.25, H2'),
REFERENCES
1. Crooke, S.T, in Antisense Drug Technology: Principles,
Strategies and Application, 2nd Ed., Crooke, S.T., Ed.,
New York: Marcel Dekker Inc., 2007, pp. 1–19.
2. Leonetti, C. and Zupi, G., Curr. Pharm. Des., 2007,
vol. 13, pp. 463–470.
3. Dash, P., Lotan, I., Knapp, M., Kandel, E.R., and Goelet, P.,
Proc. Natl. Acad. Sci. USA, 1987, vol. 84, pp. 7896–7900.
2
4. Walder, R.Y. and Walder, J.A., Proc. Natl. Acad. Sci.
USA, 1988, vol. 85, pp. 5011–5015.
4.631 (1 H, d, Ja,b 11.36, Ha PhCH2O), 4.548 (1 H, d,
2Ja,b 11.36, Hb PhCH2O), 4.131 (1 H, m, H4'), 4.077
(2 H, m, OCH2CH3), 4.445 (1 H, dd, J2',3' 5.25, J3',4' 6.88,
H3'), 2.37 (2 H, m, H6'a, H6'b), 2.111 (3 H, s,
2'-CH3COO), 2.082 (1 H, m, H5'a), 1.987 (1 H, m,
H5'b), 1.196 (3 H, t, J 7.08, OCH2CH3).
5. Micklefield, J., Curr. Med. Chem., 2001, vol. 8,
pp. 1157–1179.
6. Kurreck, J., Eur. J. Biochem., 2003, vol. 270, pp. 1628–
1644.
2'-O-Acetyl-3'-é-benzyl-5'-deoxy-5'-ethoxycar-
bonylmethyl-6-N-benzoyladenosine (IXd) was
obtained from 6-N-benzoyladenine (0.11 g, 0.45 mmol)
in absolute acetonitrile (3 ml), BSA (0.21 g, 0.25 ml,
1.03 mmol), diacetate (VIII) (0.16 g, 0.41 mmol) (a
solution in 2 ml of absolute acetonitrile), and trimethyl-
silyltriflate (0.018 g, 0.015 ml, 0.08 mmol). Elution
with methanol–chloroform 1 : 99 yielded 0.2 g (85.9%)
7. Tomohisa, M. and Kazuo, S., Front. Org. Chem., 2006,
vol. 1, pp. 163–194.
8. Hannon, G.J., Nature, 2002, vol. 418, pp. 244–251.
9. Meiste, G. and Tuschl, T., Nature, 2004, vol. 431,
pp. 343–349.
10. Kim, V.N., Han, J., and Siomi, M.C., Nature Rev. Mol.
Cell Biol., 2009, vol. 10, pp. 126–139.
1
11. Manoharan, M., Curr. Opin. Chem. Biol., 2004, vol. 8,
of nucleoside (IXd) as a solid foam; Rf 0.69 (F). H
pp. 570–579.
NMR (CDCl3): 8.768 (1 H, s, H2), 8.054 (1 H, s, H8),
8.019 (2 H, m, o-H Bz), 7.605 (1 H, m, n-H Bz), 7.521
(2 H, m, m-H, Bz), 7.39–7.26 (5 H, m, Ph), 6.065 (1 H,
d, J1',2' 3.05, H1'), 5.875 (1 H, dd, J1',2' 3.05, J2',3' 5.36,
H2'), 4.644 (1 H, d, 2Ja,b 11.35, Ha PhCH2O), 4.565 (1 H,
12. Haney, S.A., Lapan, P., Aalfs, J., Childs, C., Yaworsky, P.,
and Miller, C., in RNA Interference Technology. From
Basic Science to Drug Development, Appasani, K., Ed.,
Cambridge, New York,: Melbourne, Madrid, Cape
Town: Cambridge Univ. Press, 2005, pp. 331–347.
2
d, Ja,b 11.35, Hb PhCH2O), 4.454 (1 H, pseudo s, t, J
6.36, H3'), 4.165 (1 H, m, H4'), 4.082 (2 H, m,
OCH2CH3), 2.375 (2 H, m, H6'a, H6'b), 2.12 (3 H, s, 2'-
13. Rozners, E., Current Org. Chem., 2006, vol. 10, pp. 675–
692.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY Vol. 35 No. 5 2009